Gulf Times - remdesivir
WHO advises against Gilead's remdesivir for all hospitalised Covid-19 patients

WHO advises against Gilead's remdesivir for all hospitalised Covid-19 patients

Gilead's remdesivir is not recommended for patients hospitalised with Covid-19, regardless of how ill they are, as there is no evidence the drug improves survival or reduces the need for ventilation, a World Health Organisation ...

World's top intensive care body advises against remdesivir for sickest Covid patients

World's top intensive care body advises against remdesivir for sickest Covid patients

Antiviral remdesivir should not be used as a routine treatment for Covid-19 patients in critical care wards, the head of one of the world's top bodies representing intensive care doctors said, in a blow to the drug developed by US firm Gilead.

Row breaks out over WHO trial casting doubt on remdesivir as Covid-19 drug

Row breaks out over WHO trial casting doubt on remdesivir as Covid-19 drug

A row broke out on Friday over a World Health Organization (WHO) clinical trial which concluded that the anti-viral drug remdesivir has little or no impact on a patient's chances of surviving Covid-19.

EU buys remdesivir to treat 30,000 Covid patients, seeks more

EU buys remdesivir to treat 30,000 Covid patients, seeks more

The European Union's executive said on Wednesday it had agreed to buy a limited supply of the Covid-19 medicine remdesivir from US drugmaker Gilead to address the short-term needs of European patients

Gilead says remdesivir reduced risk of death in Covid-19 patients, more studies needed

Gilead says remdesivir reduced risk of death in Covid-19 patients, more studies needed

Gilead Sciences Inc said on Friday additional data from a late-stage study showed its antiviral remdesivir reduced the risk of death and significantly improved the conditions of severely ill Covid-19 patients.

Singapore approves remdesivir drug for emergency Covid-19 treatment

Singapore approves remdesivir drug for emergency Covid-19 treatment

Singapore on Wednesday approved the use of Gilead Sciences Inc's antiviral drug remdesivir for the treatment of severely ill patients with Covid-19 infection.

Gilead's remdesivir slows disease progression in monkeys with Covid-19

Gilead's remdesivir slows disease progression in monkeys with Covid-19

Gilead Sciences Inc's antiviral drug, remdesivir, prevented lung disease in macaques infected with the new coronavirus, according to a study published in medical journal Nature on Tuesday.

Gilead remdesivir results mixed in moderate Covid-19 patients

Gilead remdesivir results mixed in moderate Covid-19 patients

Gilead Sciences Inc said on Monday its antiviral drug remdesivir had mixed results in a late stage study of people with moderate Covid-19, as patients given a five-day course of the treatment showed

Anti-viral drug effective against coronavirus, study finds

Anti-viral drug effective against coronavirus, study finds

Anti-viral drug remdesivir cuts recovery times in coronavirus patients, according to the full results of a trial published Friday night, three weeks after America's top infectious diseases expert said the study showed

Japan's Takeda Pharma says it is developing coronavirus drug

Japan's Takeda Pharma says it is developing coronavirus drug

Takeda Pharmaceutical Co said on Wednesday it was developing a drug for high-risk patients infected with the new coronavirus, joining several other drugmakers seeking to develop a treatment for an illness that has killed over 3,000 people.